Skip to main content
ConductScienceScienceDex

Jeffrey Victor Ravetch

NIH Rank #3289
Unclaimed recordClaim profile
  • R01 Holder
  • Early Career

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 1884719Search this ID in NIH RePORTER
ScienceDex PI coverage
FY2024 through FY2026Career claims are limited to the years shown.

FY2026 award categories

  • Genetics
  • Biochemistry

NIH Funding · FY2025

Linked Award Amount
$3.1M
Full award amounts, FY2025
Award Records
5
Records listing this PI
Award-Linked Rank
#3,289
By linked amount among FY2025 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Jeffrey Victor Ravetch. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2025 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2025 award records by amount

NIH award records listing Jeffrey Victor Ravetch as a PI. Multi-PI records show the full award amount for context.

  • 5R35CA196620-11R35
    Molecular mechanisms of antibody-mediated immunotherapies
    Rockefeller University
    $1M
    award amount
  • 5R01AI145870-07R01
    Development of vaccination strategies to elicit broadly protective immunity against influenza
    Rockefeller University
    $845.1K
    award amount
  • 2R01AI149297-06R01
    Engineering IgG-specific endoglycosidases to selectively defeat effector functions
    Emory University
    $663.2K
    award amount
  • 5R01CA258324-05R01
    Engaging immunosuppressive myeloid cells in the TME for the treatment of pancreatic cancer
    Rockefeller University
    $370.7K
    award amount
  • 3R01CA258324-05S1R01
    Engaging immunosuppressive myeloid cells in the TME for the treatment of pancreatic cancer
    Rockefeller University
    $171.7K
    award amount

Award organizations

Organizations that administered FY2025 awards listing Jeffrey Victor Ravetch as a PI.

Rockefeller University
NY
$2.4M
4 grants
Emory University
GA
$663.2K
1 grant

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2024
    First NIH Award
    Rockefeller University
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    $2M Cumulative Funding
  5. 2024
    Entered Top 50% Nationally
    Ranked #2383
  6. 2024
    Entered Top 25% Nationally
    Ranked #2383
  7. 2025
    $5M Cumulative Funding
  8. 2025
    Multi-Institutional Research
    Awards at 2 institutions
  9. 2025
    R01 Grant Holder

Shared-award investigators

Other investigators listed on at least one of the same NIH award records as Jeffrey Victor Ravetch.

Mikael Karlsson
Rockefeller University
3
shared awards
Peter Palese
Rockefeller University
3
shared awards
Eric John Sundberg
Emory University
2
shared awards
Robert McCullough Anthony
Massachusetts General Hospital
2
shared awards

Explore further

Find collaborators for Jeffrey Victor Ravetch

Search NIH-funded principal investigators by topic, department, or activity.

Open Find Collaborators →

Benchmark grant budgets

Compare median NIH grant budgets across departments, mechanisms, and years.

Open Grant Budget Benchmark →